December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

33.41 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
48 49 Next >
News headline image
NYSE: HIMS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
After Its Biggest Drop Ever...Is HIMS A Buy? ↗
 
Via Benzinga
News headline image
Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
HIMS & HERS HEALTH, INC. (NYSE: HIMS) INVESTOR ALERT: Investors With Large Losses in Hims & Hers Health, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Why Hims & Hers Stock Is Crashing, and Is It a Buying Opportunity? ↗
Via The Motley Fool
News headline image
HIMS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Hims & Hers Health, Inc.
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
HIMS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Hims & Hers Health, Inc. Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
4 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
Via ACCESS Newswire
News headline image
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
BFA Law Notifies Hims & Hers Health, Inc. (HIMS) Investors that the Company is being Investigated for Securities Fraud - Contact the Firm if You Lost Money
Via ACCESS Newswire
News headline image
HIMS & HERS HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Hims & Hers CEO Says 'No Way In Hell We're Gonna Cave On' Selling Compounded Obesity Drugs After Novo Nordisk Breakup ↗
Truist warned that Hims faces renewed litigation risk after Novo's exit, which could create a prolonged legal overhang on the stock. 
Via Stocktwits
Topics Law Enforcement Lawsuit
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
Via ACCESS Newswire
News headline image
Kirby McInerney LLP Announces Investigation Against Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
HIMS INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Hims & Hers Health, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
Johnson Fistel Investigates Hims & Hers Regulatory Evasion and Investor Impact
From Johnson Fistel, PLLP
Via Business Wire
News headline image
HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail? ↗
Telehealth company Hims & Hers (HIMS) saw a 34% stock drop after Novo Nordisk (NVO) ended their relationship. Investors must decide if it's a buying opportunity or a warning sign for the industry. 
Via Benzinga
News headline image
Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy, Faces Investor Scrutiny - Hagens Berman
Via ACCESS Newswire
News headline image
NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors With Significant Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Law Enforcement
News headline image
NYSE: HIMS Investigation: Kessler Topaz Meltzer &amp; Check, LLP Encourages Hims &amp; Hers Health, Inc. (NYSE: HIMS) Investors With Significant Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud Law Enforcement
News headline image
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Why Hims & Hers Stock Could Be a Multi-Bagger in the Making
Hims & Hers stock keeps giving investors more reasons to buy, and has all the right factors to turn it into a potential multi-bagger investment. 
Via MarketBeat
Topics Economy
News headline image
Why Did Hims and Hers Stock Crash on Monday? ↗
Via The Motley Fool
News headline image
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know ↗
Via The Motley Fool
News headline image
Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed' ↗
Hims & Hers Health CEO Andrew Dudum has accused Novo Nordisk of exerting anticompetitive pressure to prioritize its weight-loss drug Wegovy. 
Via Benzinga
News headline image
Market Monitor News June 24 BMO (Tesla, Northern Trust UP - Hims&Hers, Super Micro Computer DOWN) ↗
Markets Brush Off Missiles and Missteps — Sentiment Stays Surprisingly Resilient 
Via Chartmill
News headline image
Circle Internet, AMD, Nvidia, Hims & Hers, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
On Monday, major U.S. indices ended the day in the green with the Dow Jones Industrial Average rising 0.9% to 42,581.78, and the S&P 500 gaining nearly 1% to 6,025.17. 
Via Benzinga
Topics Stocks
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.